European Dermatology Forum
The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines.
Recognising the need to address these issues, seven academic dermatologists, all heads of university departments, formed the European Dermatology Forum (EDF) in 1997 as a non-profit professional organisation dedicated to improving the healthcare needs of dermatology patients in Europe. At its inception the EDF published a document setting out its mission and this continues to remain at the core of its activities.
To implement actions aimed at preventing skin disease and improving the quality of healthcare for dermatologic & venereologic patients in Europe, notably by strengthening the position and reducing the health economic impact of dermato-venereology and its several subspecialties such as allergology and dermato-oncology to the benefit of our patients and our profession.
The EDF was founded in 1997 by a group of leading European Professors of Dermatology. The EDF is currently restricted to 200 active members consisting of heads of academic departments and key opinion leaders in dermato-venereology across Europe.
Prof. Lars French Past President 2015–2017 Zurich, Switzerland
Prof. John McGrath President 2017–2019 London, United Kingdom
The EDF supports the internet platform Cyberderm DOIT. This is a peerreviewed interactive, systematic and case-oriented, multilingual online dermatology e-learning platform for undergraduate students in Medicine (www.cyberderm.net) which is also complemented by a webbook (launched in 2017).
201821st EDF Meeting
Annual meeting takes place each January in Switzerland and is designed to address several of the significant issues impacting on dermatolovenereology, ranging from clinical to political matters.